McKesson Corporation ("McKesson") today announced the completion of the acquisition of more than 75 percent of Celesio shares. McKesson, a leading North American pharmaceutical wholesaler and provider of innovative technology and business services, is therefore the new majority shareholder in Celesio.
- Date created
McKesson concludes acquisition of more than 75 percent of Celesio shares
About Celesio Group
Celesio is a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors. The proactive and preventive approach ensures that patients receive the products and support that they require for optimum care. With 39,000 employees, Celesio operates in 14 countries around the world. Every day, the group serves over 2 million customers – at 2,200 pharmacies of its own and 4,100 participants in brand partnership schemes. With around 130 wholesale branches, Celesio supplies 65,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products. The services benefit a patient pool of about 15 million per day.
Press contact
- Meike Esser
- Spokesperson McKesson Europe
- media@mckesson.eu
- Telephone
- +49 711 5001-00
Investor Relations Contact
- Markus Georgi
- Celesio AG
- investor@celesio.com
- Telephone
- +49 711 5001-1208
Creditor Relations
- Marcus Hilger
- Celesio AG
- finance@celesio.com
- Telephone
- +49 711 5001-532
